Search Within

Ziyu Chen

Formats
  1. Meeting Abstract (6)
  2. Journal Article (4)
  3. Review (1)
Groups
  1. Department of Medicine (11)
  2. GSK Faculty (11)
  3. Genitourinary Oncology Service (11)
  4. Human Oncology and Pathogenesis Program (11)
  5. MSK Grad Students (11)
  6. Solid Tumor Oncology Division (11)

More Groups

People
  1. David Solit (11)
  2. Gopakumar Iyer (10)
  3. Hikmat Al-Ahmadie (10)
  4. Jonathan Rosenberg (8)
  5. Eugene Pietzak (6)
  6. Bernard Bochner (5)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (4)
  5. 2021 (1)
  6. 2020 (1)
Publications
  1. Cancer Research (2)
  2. Nature Communications (2)
  3. Clinical Cancer Research (1)
  4. European Journal of Cancer (1)
  5. European Urology (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. Nature Publishing Group (4)
  2. American Association for Cancer Research (3)
  3. Elsevier Inc. (2)
  4. American Society of Clinical Oncology (1)
  5. Elsevier Science, Inc. (1)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular heterogeneity and immune infiltration drive clinical outcomes in upper tract urothelial carcinoma
    Journal Article

    Kim, K.; Alam, S. M.; Kuo, F.; Chen, Z.; Yip, W.; Katims, A. B.; Chu, C.; Lenis, A. T.; Hu, W.; Gokturk Ozcan, G.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Clinical, molecular and immunohistochemical profiles of clear cell adenocarcinoma of the urinary tract
    Meeting Abstract

    Koll, F.; Rammal, R.; Chen, Z.; Basar, M.; Alam, S. M.; Tallman, J. E.; Pietzak, E.; Dalbagni, G.; Donahue, T.; Donat, S. M.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • BRAF — A tumour-agnostic drug target with lineage-specific dependencies
    Review

    Hanrahan, A. J.; Chen, Z.; Rosen, N.; Solit, D. B.
    Nature Reviews Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical and genomic landscape of FGFR3-altered urothelial carcinoma and treatment outcomes with erdafitinib: A real-world experience
    Journal Article

    Guercio, B. J.; Sarfaty, M.; Teo, M. Y.; Ratna, N.; Duzgol, C.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Regazzi, A. M.; Chen, Z.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Genomic landscape of urothelial carcinoma with divergent differentiation and histologic subtypes
    Meeting Abstract

    Chu, C.; Chen, Z.; Whiting, K.; Rammal, R.; Lenis, A.; Ozcan, G. G.; Akbulut, D.; Basar Yerebakan, M.; Chen, J. F.; Sirintrapun, S. J.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
    Meeting Abstract

    Chen, Z.; Clinton, T. N.; Park, S.; Lenis, A. T.; Donoghue, M.; Rosenberg, J. E.; Dean, B. F.; Teo, M. Y.; Bochner, B. H.; Ostrovnaya, I.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Identifying potential mechanisms of resistance to erdafitinib (erda) via longitudinal analysis of circulating tumor (ct)-DNA of patients (pts) with advanced/metastatic urothelial cancer
    Meeting Abstract

    Guercio, B. J.; Sarfaty, M.; Teo, M. Y.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Ratna, N.; Regazzi, A. M.; Chen, Z.; Lattanzi, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
    Journal Article

    Warrick, J. I.; Hu, W.; Yamashita, H.; Walter, V.; Shuman, L.; Craig, J. M.; Gellert, L. L.; Castro, M. A. A.; Robertson, A. G.; Kuo, F.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • HER2 as a therapeutic target in bladder cancer
    Meeting Abstract

    Chen, Z.; Tang, X.; Christin, J. R.; Gao, S. P.; Chu, C. E.; Berger, M. F.; Schultz, N. D.; Shen, M. M.; Al-Ahmadie, H. A.; Iyer, G.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Detection of FGFR3 alt in plasma cfDNA in metastatic UC patients receiving Erda therapy
    Meeting Abstract

    Sarfaty, M.; Teo, M. Y.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Ratna, N.; Regazzi, A. M.; Lenis, A. T.; Chen, Z.; Al-Ahmadie, H. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save